Company intelligence / Profile preview

Feng Huang Tian Dan

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Feng Huang Tian Dan (Beijing) Technology Co., Ltd. is a Chinese biopharmaceutical company focused on the development of innovative traditional Chinese medicines (TCM). Established in 2023, the company operates as an affiliate of the Lihuayi Group and works in close collaboration with Shandong Fenghuang Pharmaceutical and the Beijing University of Traditional Chinese Medicine. Its lead candidate, Manpixiao Granules (慢痞消颗粒), is a novel herbal medicine currently in Phase II clinical trials for the treatment of chronic atrophic gastritis. The company aims to modernize traditional therapies to address unmet medical needs in digestive system disorders.

Therapeutic areas: Gastroenterology
Modalities: Herbal medicineBotanical extract
Industry: Biotech

Partnerships

Beijing University of Traditional Chinese MedicineShandong Fenghuang Pharmaceutical

Beyond the preview

Go deeper on Feng Huang Tian Dan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Feng Huang Tian Dan.